Long-term effects of PUVA therapy on Israeli patients with vitiligo

Harefuah

Volumn 145, Issue 7, 2006, Pages

  Vussuki, Eyal ^a   Ziv, Michael ^b   Rosenman, Deganit ^b   David, Michael ^a  

^a TEL AVIV UNIVERSITY   (Israel)

^b TECHNION ISRAEL INSTITUTE OF TECHNOLOGY   (Israel)

Author keywords

BCC basal cell carcinoma; Dermatology; Melanoma; PUVA; SCC squamous cell carcinoma; Skin cancer; Vitiligo

Indexed keywords

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; HUMAN; INTERVIEW; ISRAEL; PUVA; SKIN CANCER; SKIN PIGMENTATION; TREATMENT DURATION; VITILIGO; CLINICAL TRIAL; MEDICAL RECORD; MIDDLE AGED; MULTICENTER STUDY; QUESTIONNAIRE; RETROSPECTIVE STUDY; TREATMENT OUTCOME;

ADULT; AGED; AGED, 80 AND OVER; HUMANS; MEDICAL RECORDS; MIDDLE AGED; PUVA THERAPY; QUESTIONNAIRES; RETROSPECTIVE STUDIES; TREATMENT OUTCOME; VITILIGO;

EID: 33748429481     PISSN: 00177768     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (19)

1. Stern RS, PUVA Follow up Study. The risk of melanoma in association with long-term exposure to PUVA. Department of Dermatology, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA, USA. J Am Acad Dermatol, 2001; 44: 755-61.
2. Stern RS & Lunder EJ, Risk of squamous cell carcinoma and methoxsalen (psoralen) and UV-A radiation (PUVA). A metaanalysis. Arch Dermatol, 1998; 134: 1582-5.
3. Honigsmann H & Schwarz T, Ultraviolet light therapy. In: Bolognia JL, Jorizzo JL & Rapini RP, (Eds): Dermatology. Mosby, 2003, pp 2109-2125.
4. Sahin S, Hindioglu U & Karaduman A, PUVA treatment of vitiligo: a retrospective study of Turkish patients. Int J Dermatol, 1999; 38: 542-5.
5. Wildfang IL, Jacobsen FK & Thestrup-Pedersen K, PUVA treatment of vitiligo: a retrospective study of 59 patients. Skin Cancer Acta Derm Venereol (Stockh), 1992; 72: 305-6.
6. Halder RM, Battle EF & Smith EM, Cutaneous malignancies in patients treated with psoralen photochemotherapy (PUVA) for vitiligo. Arch Dermatol, 1995; 131: 734-5.
7. Schallreuter KU, Tobin DJ & Panske A, Decreased photodamage and low incidence of non-melanoma skin cancer in 136 sun-exposed caucasian patients with vitiligo. Dermatology, 2002; 204: 194-201.
8. Park HS, Lee YS & Chun DK, Squamous cell carcinoma in vitiligo lesion after long-term PUVA therapy. Eur Acad Dermatol Venereol, 2003; 17: 578-80.
9. Takeda H, Mitsuhashi Y & Kondo S, Multiple squamous cell carcinomas in situ in vitiligo lesions after long-term PUVA therapy. J Am Acad Dermatol, 1998; 38(2 Pt 1): 268-270.
10. Buckley DA & Rogers S, Multiple keratoses and squamous carcinoma after PUVA treatment of vitiligo. Clin Exp Dermatol, 1996; 21: 43-5.
11. Lindelof B, Sigurgeirsson B, Tegner E & al, PUVA and cancer risk: the Swedish follow-up study. Br J Dermatol, 1999; 141: 108-12.
12. Akimoto S, Suzuki Y & Ishikawa O, Multiple actinic keratoses and squamous cell carcinomas on the sun-exposed areas of widespread vitiligo. Br J Dermatol, 2000; 142: 824-5.
13. Seo SL & Kim IH, Sqaumous cell carcinoma in a patient with generalized vitiligo. J Am Acad Dermatol, 2001; 45: s227-9.
14. Ortonne JP, Pelletier N, Chabanon M & al, Vitiligo et epitheliomas cutanes. Ann Dermatol Venereol (Paris), 1978; 105: 1063-4.
15. Lisi P, Vitiligine e cancero cutaneo. Minerva Dermatol, 1972; 47: 427-9.
16. Lassus A, Apajalahti K, Blomqvist M & al, Vitiligo and neoplasms. Acta Derm Venereol (Stockholm), 1972; 52: 229-32.
17. Calanchini-Postizzi & Frenk E, Long-term actinic damage in sun-exposed vitiligo and normaly pigmented skin. Dermatologica, 1987; 174: 266-271.
18. Schallreuter KU, Behrens-Williams S, Khaliq TP & al, Increased epidermal functioning wild-type p53 expression in vitiligo. Exp Dermatol, 2003; 12: 268-77.
19. Miller SJ & Moresi JM, Actininic keratosis, basal cell carcinoma and sqaumous cell carcinima. In: Bolognia JL, Jorizzo JL & Rapini RP, (Eds). Dermatology, Mosby, 2003, pp 1677-1696.